Suppr超能文献

接受抗癫痫药物治疗的蛛网膜下腔出血患者的预后。

Outcome in patients with subarachnoid hemorrhage treated with antiepileptic drugs.

作者信息

Rosengart Axel J, Huo J Dezheng, Tolentino Jocelyn, Novakovic Roberta L, Frank Jeffrey I, Goldenberg Fernando D, Macdonald R Loch

机构信息

Department of Neurology, Neurocritical Care and Acute Stroke Program, Section of Neurosurgery, The University of Chicago Pritzker School of Medicine, Chicago, Illinois 60637, USA.

出版信息

J Neurosurg. 2007 Aug;107(2):253-60. doi: 10.3171/JNS-07/08/0253.

Abstract

OBJECT

Prophylactic use of antiepileptic drugs (AEDs) in patients admitted with aneurysmal subarachnoid hemorrhage (SAH) is common practice; however, the impact of this treatment strategy on in-hospital complications and outcome has not been systematically studied. The goal in this study was twofold: first, to describe the prescribing pattern for AEDs in an international study population; and second, to delineate the impact of AEDs on in-hospital complications and outcome in patients with SAH.

METHODS

The authors examined data collected in 3552 patients with SAH who were entered into four prospective, randomized, double-blind, placebo-controlled trials conducted in 162 neurosurgical centers and 21 countries between 1991 and 1997. The prevalence of AED use was assessed by study country and center. The impact of AEDs on in-hospital complications and outcome was evaluated using conditional logistic regressions comparing treated and untreated patients within the same study center.

RESULTS

Antiepileptic drugs were used in 65.1% of patients and the prescribing pattern was mainly dependent on the treating physicians: the prevalence of AED use varied dramatically across study country and center (intraclass correlation coefficients 0.22 and 0.66, respectively [p < 0.001]). Other predictors included younger age, worse neurological grade, and lower systolic blood pressure on admission. After adjustment, patients treated with AEDs had odds ratios of 1.56 (95% confidence interval [CI] 1.16-2.10; p = 0.003) for worse outcome based on the Glasgow Outcome Scale; 1.87 (95% CI 1.43-2.44; p < 0.001) for cerebral vasospasm; 1.61 (95% CI 1.25-2.06; p < 0.001) for neurological deterioration; 1.33 (95% CI 1.01-1.74; p = 0.04) for cerebral infarction; and 1.36 (95% CI 1.03-1.80; p = 0.03) for elevated temperature during hospitalization.

CONCLUSIONS

Prophylactic AED treatment in patients with aneurysmal SAH is common, follows an arbitrary prescribing pattern, and is associated with increased in-hospital complications and worse outcome.

摘要

目的

在动脉瘤性蛛网膜下腔出血(SAH)患者中预防性使用抗癫痫药物(AEDs)是常见的做法;然而,这种治疗策略对住院期间并发症和预后的影响尚未得到系统研究。本研究的目标有两个:第一,描述国际研究人群中AEDs的处方模式;第二,阐明AEDs对SAH患者住院期间并发症和预后的影响。

方法

作者检查了1991年至1997年间在162个神经外科中心和21个国家进行的四项前瞻性、随机、双盲、安慰剂对照试验中收集的3552例SAH患者的数据。根据研究国家和中心评估AEDs的使用患病率。使用条件逻辑回归比较同一研究中心接受治疗和未接受治疗的患者,评估AEDs对住院期间并发症和预后的影响。

结果

65.1%的患者使用了抗癫痫药物,处方模式主要取决于治疗医生:AEDs的使用患病率在不同研究国家和中心之间差异很大(组内相关系数分别为0.22和0.66 [p < 0.001])。其他预测因素包括年龄较小、神经功能分级较差以及入院时收缩压较低。调整后,根据格拉斯哥预后量表,接受AEDs治疗的患者预后较差的优势比为1.56(95%置信区间[CI] 1.16 - 2.10;p = 0.003);发生脑血管痉挛的优势比为1.87(95% CI 1.43 - 2.44;p < 0.001);神经功能恶化的优势比为1.61(95% CI 1.25 - 2.06;p < 0.001);发生脑梗死的优势比为1.33(95% CI 1.01 - 1.74;p = 0.04);住院期间体温升高的优势比为1.36(95% CI 1.03 - 1.80;p = 0.03)。

结论

在动脉瘤性SAH患者中预防性使用AED治疗很常见,遵循任意的处方模式,并且与住院期间并发症增加和预后较差相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验